Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics

BACKGROUND: This post hoc subgroup analysis of a randomized, double-blind trial evaluated the response to treatment with two long-acting injectable atypical antipsychotics, ie, paliperidone palmitate and risperidone long-acting injectable (RLAI), in subjects with schizophrenia experiencing clinicall...

Descripción completa

Detalles Bibliográficos
Autores principales: Alphs, Larry, Bossie, Cynthia A, Sliwa, Jennifer Kern, Fu, Dong-Jing, Ma, Yi-Wen, Hulihan, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593824/
https://www.ncbi.nlm.nih.gov/pubmed/23493643
http://dx.doi.org/10.2147/NDT.S36438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593824/
https://www.ncbi.nlm.nih.gov/pubmed/23493643
http://dx.doi.org/10.2147/NDT.S36438

Ejemplares similares